|
Genomas is a biomedical company delivering Personalized Medicine to
modern clinical practice. The company develops revolutionary
PhyzioType Systems for DNA-guided management and prescription of drugs
used to treat mental illness, pain, heart disease, and
diabetes. PhyzioType Systems are designed to provide physicians with
an unprecedented capability to select for each patient the safest and
most effective drug to achieve treatment goals and enhance patient
compliance. PhyzioType Systems are composed of an ensemble of
inherited DNA polymorphisms genotyped by arrays and interpreted by a
bioclinical algorithm in order to convey to physicians predicted
comparisons of side effect risk and efficacy among drugs for the
individual patient.
The company’s clinical pharmacogenetic tests and consultation
service are provided through its Laboratory of Personalized Health
(LPH), an accredited and licensed high-complexity molecular diagnostic
center and its Personalized Health Portal (PHP), a medical informatics
interface for clinician decision support. Genomas is located on the
campus of Hartford Hospital in downtown Hartford, Connecticut.
|
